| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.21B | -2.0% |
| Gross Profit | $1.02B | -3.5% |
| R&D Expense | $196.1M | +3.3% |
| SG&A Expense | $295.3M | +70.2% |
| Operating Income | $97.4M | -62.5% |
| Pre-tax Income | $31.3M | -91.9% |
| Income Tax | $2.2M | -99.2% |
| Net Income | $29.1M | -72.9% |
| EPS (Basic) | $0.08 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $139.9M | -68.7% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $246.1M | -9.5% |
| Current Assets | $451.0M | -47.8% |
| Total Assets | $6.47B | -5.8% |
| Current Liabilities | $652.1M | +2.1% |
| Long-term Debt | $1.23B | -0.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $369.4M | -15.1% |
| Investing Cash Flow | $13.4M | -45.1% |
| Financing Cash Flow | -$690.0M | -61.5% |
| -70.4% |
| EPS (Diluted) | $0.08 | -70.4% |
| Total Liabilities |
| $4.77B |
| +0.5% |
| Stockholders' Equity | $1.69B | -20.1% |